Total Payments
$2,284
2024 Payments
$1,164
Companies
29
Transactions
70
Medicare Patients
689
Medicare Billing
$51,858
Payment Breakdown by Category
Food & Beverage$2,122 (92.9%)
Education$161.73 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,122 | 65 | 92.9% |
| Education | $161.73 | 5 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $339.23 | 8 | $0 (2024) |
| Genentech USA, Inc. | $274.14 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $238.98 | 5 | $0 (2024) |
| GT Medical Technologies, Inc | $140.00 | 1 | $0 (2023) |
| PFIZER INC. | $136.35 | 8 | $0 (2024) |
| Lilly USA, LLC | $134.92 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $132.16 | 5 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $95.09 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $94.24 | 4 | $0 (2024) |
| Incyte Corporation | $65.86 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,164 | 52 | PFIZER INC. ($136.35) |
| 2023 | $383.45 | 7 | AstraZeneca Pharmaceuticals LP ($158.74) |
| 2022 | $15.08 | 1 | Lilly USA, LLC ($15.08) |
| 2021 | $299.89 | 4 | Celgene Corporation ($125.00) |
| 2019 | $219.46 | 3 | Genentech USA, Inc. ($89.82) |
| 2018 | $68.93 | 1 | Genentech USA, Inc. ($68.93) |
| 2017 | $133.05 | 2 | Genentech USA, Inc. ($115.39) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: HEMATOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.14 | General |
| 11/20/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Rare Disease | ||||||
| 11/14/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: HEMATOLOGY | ||||||
| 10/16/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Hematology | ||||||
| 09/23/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.26 | General |
| Category: Hematology | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 184 | 266 | $61,742 | $13,918 |
| 2022 | 5 | 225 | 372 | $87,542 | $20,108 |
| 2021 | 7 | 191 | 220 | $57,965 | $13,182 |
| 2020 | 3 | 89 | 94 | $23,712 | $4,650 |
Total Patients
689
Total Services
952
Medicare Billing
$51,858
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 185 | $39,405 | $8,838 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 36 | $11,304 | $2,558 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $9,193 | $1,928 | 21.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 16 | $1,840 | $593.67 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 255 | $54,315 | $12,685 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 63 | $19,782 | $4,443 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $8,876 | $1,875 | 21.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 15 | $3,150 | $843.50 | 26.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,419 | $260.94 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 80 | $17,040 | $3,879 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 39 | $12,246 | $2,981 | 24.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 40 | 40 | $12,680 | $2,531 | 20.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $9,196 | $2,096 | 22.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 19 | $3,990 | $1,095 | 27.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 11 | $1,265 | $337.19 | 26.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 12 | $1,548 | $262.35 | 16.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 36 | 36 | $11,412 | $2,035 | 17.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 40 | $8,520 | $1,601 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 18 | $3,780 | $1,014 | 26.8% |
About Dr. Padrica Hopkins-Menchion, MD
Dr. Padrica Hopkins-Menchion, MD is a Hematology & Oncology healthcare provider based in Stockbridge, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306824800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Padrica Hopkins-Menchion, MD has received a total of $2,284 in payments from pharmaceutical and medical device companies, with $1,164 received in 2024. These payments were reported across 70 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,122).
As a Medicare-enrolled provider, Hopkins-Menchion has provided services to 689 Medicare beneficiaries, totaling 952 services with total Medicare billing of $51,858. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Stockbridge, GA
- Active Since 01/04/2006
- Last Updated 08/24/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1306824800
Products in Payments
- GAZYVA (Biological) $205.21
- GAMMATILE (Device) $140.00
- IMFINZI (Biological) $127.45
- VERZENIO (Drug) $119.84
- MONOFERRIC (Drug) $95.09
- Revlimid (Drug) $88.36
- Rituxan (Biological) $68.93
- MONJUVI (Drug) $65.86
- SCEMBLIX (Drug) $60.94
- FRUZAQLA (Drug) $59.12
- Cabometyx (Drug) $58.94
- EPKINLY (Drug) $53.37
- XPOVIO (Drug) $51.50
- LIBTAYO (Biological) $51.33
- DARZALEX (Biological) $50.23
- SARCLISA (Biological) $49.73
- TAGRISSO (Drug) $48.10
- INLYTA (Drug) $47.94
- REBLOZYL (Biological) $42.58
- BOSULIF (Drug) $39.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Stockbridge
Dr. Jorge Spinolo, Md, MD
Hematology & Oncology — Payments: $22,986
Hematology & Oncology $22,986
Gurinderjit Kaur Sidhu, Md, MD
Hematology & Oncology — Payments: $5,967
Hematology & Oncology $5,967
Dr. Anthony Onyegbula, D.o, D.O
Hematology & Oncology — Payments: $4,685
Hematology & Oncology $4,685
Lijo Simpson, Mbbs, MBBS
Hematology & Oncology — Payments: $4,517
Hematology & Oncology $4,517
Dr. Ruth Sarmiento, M.d, M.D
Hematology & Oncology — Payments: $3,789
Hematology & Oncology $3,789
Dr. Ha Tran, M.d, M.D
Hematology & Oncology — Payments: $2,994
Hematology & Oncology $2,994